Tegoprazan vs. Placebo in Non-erosive Reflux Disease Tegoprazan vs. Placebo in Non-erosive Reflux Disease

Is tegoprazan, a novel, long-acting potassium-competitive acid blocker, superior to placebo in patients with non-erosive reflux disease?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news